MDGL
#809
Madrigal Pharmaceuticals, Inc. - Common Stock
533.7 6 USD
-0.02%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-1.83%
Changement Mensuel
+15.49%
Evolution sur 6 mois
+24.06%
Changement Annuel
+26.00%
Clôture Précédente
543.6 9
Open
533.7 6
Low
533.7 6
High
533.7 6
Volume
81
Financials
- Market Capitalization 12.33 B
- Employee 915
- Founded 2011
- CEO Paul A. Friedman
- Website www.madrigalpharma.com
- Headquarter Delaware, United States
- FIGI BBG000QS6NV8
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-35.68
ratio cours/chiffre d'affaires
10.67
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 759 |  EXEL Exelixis, Inc. - Common Stock | 54.45 USD | -1.47% | +1.04% | +3.46% | +39.47% | 13.49 B USD | ||
| 799 |  BMRN BioMarin Pharmaceutical Inc. - Common Stock | 64.67 USD | -0.95% | -2.85% | +7.02% | +10.74% | 12.52 B USD | ||
| 810 |  CORT Corcept Therapeutics Incorporated - Common Stock | 113.88 USD | -2.61% | -5.54% | -0.25% | +55.21% | 12.31 B USD | ||
| 823 |  ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | 84.91 USD | -4.15% | -2.14% | +1.53% | +117.16% | 11.99 B USD |